Lymphangioleiomyomatosis--Presence of Receptor Tyrosine Kinases and the Angiogenesis Factor VEGF-A as Potential Therapeutic Targets

Thorax - United Kingdom
doi 10.1136/thx.2006.071811
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Endothelial Epsins as Regulators and Potential Therapeutic Targets of Tumor Angiogenesis

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2016English

Non-Receptor Protein-Tyrosine Kinases as Molecular Targets for Antiangiogenic Therapy (Review)

International Journal of Molecular Medicine
MedicineGenetics
2007English

Receptor Tyrosine Kinases and Schistosome Reproduction: New Targets for Chemotherapy

Frontiers in Genetics
GeneticsMolecular Medicine
2014English

Roles of C-Met and RON Kinases in Tumor Progression and Their Potential as Therapeutic Targets

Oncotarget
Oncology
2015English

Receptor Tyrosine Kinase (RTK); VEGF-A

Science-Business eXchange
2014English

Receptor Tyrosine Kinases (RTKs) in Breast Cancer: Signaling, Therapeutic Implications and Challenges

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Receptor Tyrosine Kinases in the Nucleus

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2013English

Irreversible Modifications of Receptor Tyrosine Kinases

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2018English

The Role of Steroid Receptor Coactivators in Hormone Dependent Cancers and Their Potential as Therapeutic Targets

Hormones and Cancer
OncologyCancer ResearchEndocrinologyAutonomic SystemsEndocrineMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy